Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Adjuvant Setting
11%
Adrenergic Receptors
22%
Angiosarcoma
33%
Anticancer Treatment
11%
Cancer Institute
11%
Clinical Response
22%
CT-like MRI
11%
Cutaneous Angiosarcoma
100%
Escalating Dose
11%
Ethical Approval
11%
Ethical Committee
11%
Ethics
11%
Hemangioma
11%
Histological Response
22%
Immunohistochemical Staining
11%
Infantile Hemangioma
22%
Ki-67
11%
Malignancy
11%
Malignant Growth
11%
Metastatic Potential
11%
Metastatic Recurrence
11%
Monotherapy
100%
Neoadjuvant
11%
Neoadjuvant Trials
100%
Netherlands
22%
New Treatment Options
11%
Optimal Treatment
11%
Peer-reviewed Journals
11%
Potential Rate
11%
Proliferation Index
11%
Proof of Concept Study
100%
Propranolol
100%
Receptor Expression
11%
Recurrence Rate
11%
Recurrent or Metastatic
11%
Registration number
11%
Repurposing
11%
Response Evaluation Criteria in Solid Tumors (RECIST)
11%
Trial Registration
11%
Vascular Endothelial Growth Factor
11%
Window of Opportunity Study
11%
Medicine and Dentistry
Adrenergic Receptor
22%
Angiosarcoma
100%
Cancer
11%
Cancer Staging
11%
Capillary Hemangioma
22%
Hemangioma
11%
Immunohistochemistry
11%
Magnetic Resonance Imaging
11%
Malignant Neoplasm
11%
Metastasis Potential
11%
Monotherapy
100%
Photograph
11%
Propranolol
100%
Receptor
11%
Receptor Expression
11%
Recurrence Risk
11%
Vasculotropin
11%